Episode 1 – Biological DMARDs: Medication and patient considerations

Hear about the armamentarium of biological therapies available for the treatment of rheumatic disease, including biological DMARDs (disease-modifying antirheumatic drugs), and how they may slow the progression of arthritis. Professor Peter Taylor and Professor Rieke Alten discuss how different anti-TNFs may better suit different patients and the issue of anti-drug antibodies.